Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07199530

Association Between Plasma D Dimer in Adult CAP and Severity of Inflammatory Response and Survival

Association Between Elevated Plasma D-dimer in Adult Community-acquired Pneumonia Patients and Severity of Inflammatory Response and Survival

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This observational study aims to investigate the association between elevated plasma D-dimer levels and the inflammatory response, as well as its impact on survival in adult patients with community-acquired pneumonia. the study participants will be subjected to sampling for D-dimer and calculation of CURB-65 score. this aims to find the relation between them

Detailed description

Community-acquired pneumonia (CAP) is a common and potentially life-threatening infection that affects millions of individuals worldwide each year. D-dimer is a fibrin degradation product that is elevated in many conditions associated with inflammation and coagulation activation, including pneumonia. This is an observational study including a minimum of 50 patients with CAP Patients who will be admitted to the Chest department, or coming to the outpatient clinic at Ain-Shams University Hospitals with CAP, and have the following inclusions: 1. age ≥18 years 2. diagnosis of CAP based on clinical symptoms, laboratory findings, and radiological evidence. 3. Did not have any clinical or radiological signs suggesting COVID-19 pneumonia Exclusion criteria Patients with a history of coagulation disorders, cancer, or other chronic diseases, or refusal to participate. All patients will be subjected to the following: - 1. Full medical history, demographics 2. Thorough clinical examination. 3. laboratory values (including white blood cell count, CRP, and D-dimer), With pre and post sample known precautions (8). 4. Radiological findings (CXR). 5. Severity of illness (based on the CURB-65 score).

Conditions

Interventions

TypeNameDescription
OTHERBlood Productblood sample for D-dimer

Timeline

Start date
2025-03-23
Primary completion
2026-03-01
Completion
2026-04-01
First posted
2025-09-30
Last updated
2026-02-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07199530. Inclusion in this directory is not an endorsement.